Comments
GSK files for U.S. approval of new diabetes drug
15.01.2013. | LONDON (Reuters) - GlaxoSmithKline said on Monday it had filed for U.S. approval of its new once-weekly diabetes drug albiglutide and would make a similar submission shortly in Europe as it vies for a share of a crowded market....
